CREB5 and colorectal carcinoma: Overexpression of CREB5 was significantly associated with aggressive cellular characteristics of CRC (e.g., an advanced WHO stage and an advanced TNM stage) and poorer patient outcomes, suggesting that CREB5 might be an oncogene and a prognostic marker of CRC progression.